IMMUNIC, INC. — Director's Dealing 2022

Jan 3, 2022

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2021-12-31

Reporting Person: Nash Duane (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-08	Common Stock	G	3000	—	Disposed	12032	Direct

Footnotes

F1: Represents a gift of stock.